Showing 140 news articles about Injectable & long-acting HIV treatment

Filters Content type: Editors' picks Topic: Injectable & long-acting HIV treatment

Research into injectable medications and other innovative forms of HIV treatment. It is hoped that they may only need to be taken every few weeks or months, rather than daily.

 

People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits regulatory application to EMA for the first monthly, injectable treatment for HIV

Editor's pick
ViiV press release
30 July 2019
People with limited treatment options

EMA panel recommends ibalizumab for multidrug-resistant HIV-1

Editor's pick
Medscape (requires free registration)
30 July 2019
Injectable & long-acting HIV treatment

ViiV Healthcare announces start of first-ever study to identify and evaluate approaches to implementing its once-monthly injectable HIV treatment in clinical practice

Editor's pick
ViiV Healthcare press release
11 July 2019
Injectable & long-acting HIV treatment

Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics

Editor's pick
Lyndra Therapeutics press release
10 July 2019
Injectable & long-acting HIV treatment

Study Finds Long-Acting HIV Meds Are Acceptable to Many People, but Differences Exist Among Groups

Editor's pick
The Body Pro
25 June 2019
Injectable & long-acting HIV treatment

NIH Trial Evaluates Long-acting HIV Medication Unable to Adhere to Strict Daily Regimens

Editor's pick
National Institute of Allergy and Infectious Diseases
9 May 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits New Drug Application to US FDA for the first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine

Editor's pick
ViiV press release
29 April 2019
Injectable & long-acting HIV treatment

Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

Editor's pick
The Body Pro
16 April 2019
Injectable & long-acting HIV treatment

Jose Arribas, MD, on the Challenges That Come With Long-Acting Injectables

Editor's pick
Contagion Live
15 April 2019
Treatment simplification strategies

Laura Waters, MD, FRCP: Can Two Drugs Tango?

Editor's pick
Contagion Live
12 March 2019
Injectable & long-acting HIV treatment

Long-acting injectible antiretroviral trial begins

Editor's pick
Science Speaks
28 February 2019
Injectable & long-acting HIV treatment

Emerging options: Doctors and advocates discuss treatment and prevention breakthroughs on the horizon

Editor's pick
Positively Aware
30 January 2019
Injectable & long-acting HIV treatment

ViiV’s Long-Acting Injectable HIV Regimen Boasts Good 3-Year Results

Editor's pick
Poz
5 November 2018
New & experimental HIV treatments

Long-lasting HIV injection is a step closer after second GSK study

Editor's pick
Reuters
31 October 2018
New & experimental HIV treatments

Long-acting injectable implant shows promise for HIV treatment and prevention

Editor's pick
University of North Carolina
9 October 2018
People with limited treatment options

Ibalizumab Provides New Option for Patients with Multidrug-Resistant HIV

Editor's pick
MD Magazine
23 August 2018
Injectable & long-acting HIV treatment

Swapping daily pills for monthly shots could transform HIV treatment and prevention

Editor's pick
Science
23 August 2018
New & experimental HIV treatments

Should Gilead Be Worried About This New Monthly HIV Medication?

Editor's pick
Motley Fool
16 August 2018
New & experimental HIV treatments

Is the World Ready for Long-Acting HIV Treatment?

Editor's pick
The Body Pro
11 June 2018
New & experimental HIV treatments

China approves Albuviritide: first domestically developed, long-acting injectable anti-HIV drug

Editor's pick
Firstpost
6 June 2018
New & experimental HIV treatments

Ibalizumab-uiyk for HIV: What Pharmacists Should Know

Editor's pick
Pharmacy Times
27 March 2018
New & experimental HIV treatments

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

Editor's pick
Yale News
8 January 2018
New & experimental HIV treatments

HIV Drugs in the Pipeline: Expected Approvals for 2018

Editor's pick
Infectious Disease Special Edition
31 December 2017